Tector Therapeutics Revenue
Biotechnology Research • 
Boston, Massachusetts, United States • 1-10 Employees
$
Tector Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Tector Therapeutics
Nikolaos Tsopoulidis
Lead Scientist (Co-Founder)
Company overview
| Headquarters | 127 Western Ave, Boston, Massachusetts 02134, US |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
About Tector Therapeutics
Tector Therapeutics is developing innovative cellular technologies with the potential to address significant challenges in medicine. Our work bridges cutting-edge science and practical application, with the goal of delivering meaningful patient impact.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Tector Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Tector Therapeutics has never raised funding before.
Netherlands
United Kingdom
Canada
Frequently asked questions
Tector Therapeutics is located in Boston, Massachusetts, US.
Tector Therapeutics generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
Tector Therapeutics has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Tector Therapeutics was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
Tector Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
